Analyst raises target for Medipal stock to JPY 3,600

Published on 10/07/2026 at 06:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached JPY 989.50 billion in fiscal first quarter 2027, up from JPY 905.69 billion. Medipal stock posted JPY 66.66 earnings per share.

Medipal, JP3268950007, Illustration mit AI erstellt.

Medipal (ISIN JP3268950007) received a JPY 3,600 price target on September 18, 2026, up from JPY 2,820, after a US securities firm shifted its rating from Underperform to Buy, as Yahoo Finance reported on September 24, 2026. The target change gives the latest analyst action a clear numerical anchor.

First-quarter revenue accelerates

Medipal reported revenue of JPY 989.50 billion in the first quarter of fiscal 2027, compared with JPY 905.69 billion in the fourth quarter of fiscal 2026. Yahoo Finance lists GAAP earnings per share at JPY 66.66 and net income at JPY 13.65 billion for the first quarter of fiscal 2027.

The earnings comparison is equally notable: net income rose from JPY 5.12 billion in the fourth quarter of fiscal 2026 to JPY 13.65 billion in the first quarter of fiscal 2027. The figures point to stronger quarterly profitability, although the business remains a low-margin distribution operation with a first-quarter profit margin of 1.38 percent.

Target remains above the market

The four-analyst consensus cited by Yahoo Finance was JPY 2,950 on September 17, 2026, while the average target in the same market coverage stood at JPY 3,145. The JPY 3,600 target is therefore above both the consensus and the average, but the source described the upgrading securities firm without naming it.

Medipal operates primarily in the wholesale distribution of prescription pharmaceuticals in Japan and also handles medical equipment, diagnostic reagents, logistics and related healthcare services. Its scale is reflected in the 13,024 employees reported in company profile data, while the fiscal 2027 first-quarter balance sheet showed total assets of JPY 1.94 trillion.

Tokyo price stays below yearly high

On the Tokyo Stock Exchange, Medipal was trading at JPY 2,947.50 on October 7, 2026 at 1:32 p.m. JST, down 0.30 percent versus the prior close of JPY 2,956.50. The market capitalization was JPY 603.3 billion, and the price stood 7.37 percent below the 52-week high of JPY 3,182.00, within a range of JPY 2,456.50 to JPY 3,182.00.

The dormant Lang & Schwarz quote record shows a prior close of EUR 16.60 for October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Medipal stock.